Siegfried Looser

Title: Siegfried Looser: Innovator in Cardiac Biomarkers

Introduction

Siegfried Looser is a notable inventor based in Manheim, Germany. He has made significant contributions to the field of cardiac biomarkers, particularly through his work on troponin T. With a total of 2 patents, his innovations have the potential to enhance the diagnosis of myocardial necrosis.

Latest Patents

Looser's latest patents focus on specific antibodies to troponin T and their applications in immunoassays. One of his patents describes an immunoassay for determining myocardial necroses using antibodies to troponin T. This method involves a binding partner for troponin T, where either the antibody or the binding partner is labeled with a determinable group. The formed immunological complex is isolated, allowing for the determination of the group in one of the phases. Additionally, he has developed monoclonal and polyclonal antibodies to troponin T, which exhibit minimal cross-reactivity with skeletal muscle troponin T and other myofibrillar proteins.

Career Highlights

Siegfried Looser is associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics. His work has been instrumental in advancing the understanding and detection of cardiac conditions, particularly through the development of innovative diagnostic tools.

Collaborations

Looser has collaborated with notable professionals in his field, including Hugo Katus, to further enhance the research and development of cardiac biomarkers.

Conclusion

Siegfried Looser's contributions to the field of cardiac diagnostics through his patents on troponin T antibodies are significant. His work continues to pave the way for improved diagnostic methods in the medical field.